Management of the single liver nodule in a cirrhotic patient: A decision analysis model

Journal of Clinical Gastroenterology

Volumn 39, Issue 2, 2005, Pages 152-159

  El Serag, Hashem B ^a,b   Mallat, Damien B ^a   Rabeneck, Linda ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Decision analysis; Hepatocellular carcinoma; Liver nodule; Local therapy; Orthotopic liver transplantation; Surgery; Ultrasound guided biopsy

Indexed keywords

ALPHA FETOPROTEIN;

ARTICLE; DECISION ANALYSIS MODEL; DECISION SUPPORT SYSTEM; FOLLOW UP; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; LIVER TRANSPLANTATION; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROBABILITY; SURVIVAL TIME; TREATMENT OUTCOME;

BIOPSY; CARCINOMA, HEPATOCELLULAR; DECISION SUPPORT TECHNIQUES; DISEASE-FREE SURVIVAL; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; PROBABILITY THEORY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 12344334827     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med. 2000;160:3227-3230.
2. El-Serag HB, Everhart JE. Improved survival following variceal hemorrhage over an 11-year period in the Department of Veteran Affairs. Am J Gastroenterol. 2000;95:3566-3573.
3. Dancey JE, Shepherd FA. Carcinoma of the liver. In: Foley JF, Vose JM, Armitage JO, eds. Current Therapy in Cancer, 2nd ed. Philadelphia: Saunders, 1999:81.
4. Figueras J, Jaurrieta E, Valls C, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology. 1997;25:1485-1489.
5. Durand F, Regimbeau JM, Belghiti J, et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol. 2001;35:254-258.
6. Huang GT, Sheu JC, Yang PM, et al. Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma: a study based on 420 patients. J Hepatol. 1996;25:334-338.
7. UNOS Scientific Registry Data as of September 05, 2000.
8. Figueras J, Ibanez L, Ramos E, et al. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Liver Transpl. 2001;7:877-883.
9. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30:1434-1440.
10. Sakon M, Umeshita K, Nagano H, et al. Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves. Arch Surg. 2000;135:1456-1459.
11. Orlando A, Cottone M, Virdone R, et al. Treatment of small hepatocellular carcinoma associated with cirrhosis by percutaneous ethanol injection: a trial with a comparison group. Scand J Gastroenterol. 1997;32:598-603.
12. Lee HM, Lu DS, Krasny RM, et al. Hepatic lesion characterization in cirrhosis: significance of arterial hypervascularity on dual-phase helical CT. AJR Am J Roentgenol. 1997;169:125-130.
13. Di Bisceglie A. Malignant neoplasms of the liver. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiffs Diseases of the Liver, vol. 2, 8th ed. Philadelphia: Lippincott Raven, 1999:1281-1304.
14. Hu KQ, Tong MJ. The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States. Hepatology. 1999;29:1311-1316.
15. Kim WR, Poterucha JJ, Jorgensen RA, et al. Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C. Ann Intern Med. 1997;127:866-874.
16. Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology. 1997;112:463-472.
17. Colombo M, de Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med. 1991;325:675-680.
18. Kato Y, Nakata K, Omagari K, et al. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan: analysis of infectious hepatitis viruses. Cancer. 1994;74:2234-2238.
19. Bolondi L, Sofia S, Siringo S, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut. 2001;48:251-259.
20. Llovet JM, Bustamante J, Castells A, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999;29:62-67.
21. Bennett WG, Inoue Y, Beck JR, et al. Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C. Ann Intern Med. 1997;127:855-865.
22. Villa E, Moles A, Ferretti I, et al. Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival. Hepatology. 2000;32:233-238.
23. Longchampt E, Patriarche C, Fabre M. Accuracy of cytology vs. microbiopsy for the diagnosis of well-differentiated hepatocellular carcinoma and macroregenerative nodule: definition of standardized criteria from a study of 100 cases. Acta Cytol. 2000;44:515-523.
24. Yu SC, Lau WY, Leung WT, et al. Percutaneous biopsy of small hepatic lesions using an 18 gauge automated needle. Br J Radiol. 1998;71:621-624.
25. Yu SC, Liew CT, Lau WY, et al. US-guided percutaneous biopsy of small (< or = 1-cm) hepatic lesions. Radiology. 2001;218:195-199.
26. Lim JH, Kim CK, Lee WJ, et al. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients. AJR Am J Roentgenol. 2000;175:693-698.
27. Miller WJ, Baron RL, Dodd GD 3rd, et al. Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients. Radiology. 1994;193:645-650.
28. Orlando A, D'Antoni A, Camma C, et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: a validated prognostic model. Am J Gastroenterol. 2000;95:2921-2927.
29. Castellano L, Calandra M, Del Vecchio Blanco C, et al. Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients. J Hepatol. 1997;27:862-870.
30. Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology. 2000;32:1224-1229.
31. Hanazaki K, Kajikawa S, Shimozawa N, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg. 2000;191:381-388.
32. Bismuth H, Chiche L, Adam R, et al. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg. 1993;218:145-151.
33. Fan ST, Lai EC, Lo CM, et al. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg. 1995; 130:198-203.
34. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-699.
35. Iwatsuki S, Dvorchik I, Marsh JW, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 2000;191:389-394.
36. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg. 1998;228:479-490.
37. Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 1996;334: 815-820.
38. Boker KH, Dalley G, Bahr MJ, et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology. 1997;25:203-210.
39. Kilpe VE, Krakauer H, Wren RE. An analysis of liver transplant experience from 37 transplant centers as reported to Medicare. Transplantation. 1993;56:554-561.
40. Chapoutot C, Perney P, Fabre D, et al. Needle-tract seeding after ultrasound-guided puncture of hepatocellular carcinoma: a study of 150 patients. Gastroenterol Clin Biol. 1999;23:552-556.
41. Kim SH, Lim HK, Lee WJ, et al. Needle-tract implantation in hepatocellular carcinoma: frequency and CT findings after biopsy with a 19.5-gauge automated biopsy gun. Abdom Imaging. 2000;25:246-250.
42. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421-430.
43. Yamamoto J, Okada S, Shimada K, et al. Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology. 2001;34:707-713.
44. Lencioni R, Paolicchi A, Bartolozzi C. Percutaneous alcohol administration for hepatocarcinoma: long-term results. Radiol Med. 1997;94:8-13.